Effects of different inflatable heater temperature settings on early postoperative recovery after hysteroscopic surgery: a randomized clinical trial
Clinical Snapshot
PICO Framework
| P — Population | Adult women undergoing hysteroscopic myomectomy under laryngeal mask general anaesthesia |
| I — Intervention | Perioperative inflatable warming device set to 43°C |
| C — Comparator | Perioperative inflatable warming device set to 38°C |
| O — Outcomes | Primary: QoR-40 score at 24 hours postoperatively; Secondary: core body temperature, haemodynamic parameters, postoperative complications |
Bottom Line
This RCT suggests that using inflatable warming devices at 43°C versus 38°C during hysteroscopic myomectomy may improve early postoperative recovery quality at 24 hours without increasing complications. However, significant methodological limitations including unclear randomisation, high attrition without explanation, lack of blinding, and absence of confidence intervals substantially limit confidence in these findings. The study provides insufficient detail on effect size and clinical significance. While the intervention is low-risk and easily implemented, clinicians should await higher-quality evidence before changing current perioperative warming protocols. The biological plausibility of better temperature maintenance improving recovery is reasonable, but this study's design flaws prevent definitive clinical recommendations.
Key Findings
P Value: P < 0.05
Effect Size: Not reported
Primary Outcome: QoR-40 score significantly higher in 43°C group at 24 hours postoperatively
Nnt Or Sensitivity: Not calculable from available data
Confidence Interval: Not reported
Clinical Application
High - inflatable warming devices widely available in Australian operating theatres with simple temperature adjustment Relevant to Australian practice; perioperative hypothermia prevention aligns with ANZCA guidelines and patient safety initiatives Adult women undergoing hysteroscopic procedures under general anaesthesia in Australian hospitals
Abstract
To investigate the effect of perioperative temperature settings of an inflatable warming device on postoperative recovery quality in patients undergoing hysteroscopic myomectomy, this randomized controlled trial enrolled 258 patients receiving laryngeal mask general anesthesia at Xuzhou Central Hospital, China, between March 2022 and August 2024. Patients were allocated to perioperative temperature management with an inflatable warming device set to 38 °C (Group L, n = 129) or 43 °C (Group H, n = 129). A total of 211 patients were included in the final analysis after accounting for exclusions. At 24 h postoperatively, the QoR-40 score was significantly higher in Group H compared to Group L (P < 0.05). At baseline (T0), no significant differences in core body temperature, mean arterial pressure (MAP), or heart rate (HR) were observed between groups (P > 0.05). From T1 to T6, Group H exhibited higher and more stable core body temperature, MAP, and HR compared to Group L (P < 0.05). There were no statistically significant differences in QoR-40 scores at 48 h (P > 0.05) or in the incidence of postoperative restlessness, chills, and infection between the two groups. Compared to 38 °C, the perioperative application of a 43 °C inflatable warming device improved early postoperative recovery quality at 24 h in hysteroscopic myomectomy patients without increasing complication risks.
References
- 1.Song, X., Qi, Y., Ren, Y., Zhang, F., Zhang, L., Zhou, M., & Zhang, J. (2026). Effects of different inflatable heater temperature settings on early postoperative recovery after hysteroscopic surgery: a randomized clinical trial. Scientific Reports. https://doi.org/10.1242/jeb.243152
Related Research
JMIR formative research
Development of a User-Informed Decision Aid for Contraceptive Decision-Making Among Adolescents and Young Adults: Qualitative Study
22 July 2026
JMIR formative research
Effects of Virtual Reality on Postoperative Pain Management Following Minimally Invasive Gynecologic Surgery: Randomized Controlled Trial
5 July 2026
Advanced drug delivery reviews
Artificial intelligence and machine learning in smart vaginal formulation development
1 July 2026
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service